• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[在命名测试中E280A突变携带者和非携带者对家族性阿尔茨海默病的表现]

[Performance of carriers and non-carriers of the E280A mutation for familial Alzheimer's disease in a naming test].

作者信息

Tirado V, Muñoz C, Aguirre C, Pineda D A, Lopera F

机构信息

Grupo de Neurociencias, Universidad de Antioquia, Medellin, Colombia.

出版信息

Rev Neurol. 2004;39(4):322-6.

PMID:15340889
Abstract

INTRODUCTION

Early preclinical diagnosis is the greatest challenge faced by researchers into dementia. Cognitive, neuroanatomical, neurophysiological and genetic markers have been reported. One of the preclinical cognitive markers is anomia and it is often assessed using visual naming tests.

AIMS

The aim of this study was to analyse the type of mistakes made in a visual naming test in a group of carriers and non-carriers of the E280A PS1 mutation.

PATIENTS AND METHODS

The sample was made up of 91 participants who were genotyped for the E280A PS1 mutation and divided into three groups: non-carriers (n = 30), asymptomatic carriers (n = 39) and sick carriers (n = 22). Selection was performed using the Minimental and the Fast and EDG scales and mistakes in the CERAD naming test were classified. The types of mistakes taken into account were: no answer, visual, semantic, phonological, the whole for the part, and not related.

RESULTS

There is a significant difference in the number of semantic errors between non-carriers and asymptomatic carriers; on comparing the three groups, no statistically significant differences were found in visual mistakes.

CONCLUSIONS

Visual mistakes are a general characteristic, even in healthy subjects and, therefore, these errors did not provide any information that could be used to classify patients with or without dementia. Semantic mistakes can be considered as being a preclinical sign in familial Alzheimer's disease (FAD). Both visual and auditory naming tests must be applied when evaluating patients with FAD.

摘要

引言

早期临床前诊断是痴呆症研究人员面临的最大挑战。认知、神经解剖学、神经生理学和基因标记物均有相关报道。临床前认知标记物之一是命名障碍,通常使用视觉命名测试进行评估。

目的

本研究旨在分析一组E280A PS1突变携带者和非携带者在视觉命名测试中所犯错误的类型。

患者与方法

样本由91名参与者组成,他们接受了E280A PS1突变的基因分型,并分为三组:非携带者(n = 30)、无症状携带者(n = 39)和患病携带者(n = 22)。使用简易精神状态检查表和快速及EDG量表进行筛选,并对CERAD命名测试中的错误进行分类。所考虑的错误类型包括:无回答、视觉性、语义性、语音性、以整体代部分以及无关错误。

结果

非携带者和无症状携带者在语义错误数量上存在显著差异;在比较三组时,未发现视觉错误有统计学上的显著差异。

结论

视觉错误是一个普遍特征,即使在健康受试者中也是如此,因此,这些错误并未提供可用于对有无痴呆症患者进行分类的任何信息。语义错误可被视为家族性阿尔茨海默病(FAD)的临床前体征。在评估FAD患者时,必须同时应用视觉和听觉命名测试。

相似文献

1
[Performance of carriers and non-carriers of the E280A mutation for familial Alzheimer's disease in a naming test].[在命名测试中E280A突变携带者和非携带者对家族性阿尔茨海默病的表现]
Rev Neurol. 2004;39(4):322-6.
2
[Analysis of intrusive errors in a memory test as possible pre-clinical marker of familial Alzheimer disease, in E280A presenilin-1 mutation carrier].
Rev Neurol. 2008;47(6):290-4.
3
Cognitive decline in patients with familial Alzheimer's disease associated with E280a presenilin-1 mutation: a longitudinal study.携带E280a早老素-1突变的家族性阿尔茨海默病患者的认知衰退:一项纵向研究。
J Clin Exp Neuropsychol. 2000 Aug;22(4):483-95. doi: 10.1076/1380-3395(200008)22:4;1-0;FT483.
4
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.家族性阿尔茨海默病突变的临床前和症状前携带者的扩散张量成像
Brain. 2007 Jul;130(Pt 7):1767-76. doi: 10.1093/brain/awm102. Epub 2007 May 23.
5
[Image characterization of Alzheimer's disease associated with the E280A-PS1 mutation. Case-control study: MRI findings].
Rev Neurol. 1999;29(1):6-12.
6
Neuropsychological profile of a large kindred with familial Alzheimer's disease caused by the E280A single presenilin-1 mutation.
Arch Clin Neuropsychol. 2000 Aug;15(6):515-28.
7
Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred.载脂蛋白Eε4在一个E280A早老素1家族中改变了阿尔茨海默病的发病情况。
Ann Neurol. 2003 Aug;54(2):163-9. doi: 10.1002/ana.10636.
8
CA1 hippocampal neuronal loss in familial Alzheimer's disease presenilin-1 E280A mutation is related to epilepsy.家族性阿尔茨海默病早老素-1 E280A突变导致的海马CA1区神经元丢失与癫痫有关。
Epilepsia. 2004 Jul;45(7):751-6. doi: 10.1111/j.0013-9580.2004.55403.x.
9
[Detection of antibodies to beta-amyloid in carriers of E280A mutation in the presenilin-1 gene].[早老素-1基因E280A突变携带者中β-淀粉样蛋白抗体的检测]
Rev Neurol. 1999;29(12):1104-7.
10
Cognitive changes in the preclinical phase of familial Alzheimer's disease.家族性阿尔茨海默病临床前期的认知变化
J Clin Exp Neuropsychol. 2007 Nov;29(8):892-900. doi: 10.1080/13803390601174151. Epub 2007 Feb 19.

引用本文的文献

1
Cognitive Outcomes in Autosomal-Dominant Alzheimer's Disease: A Comprehensive Review from a Colombian Kindred with the Presenilin-1 E280A Mutation.常染色体显性阿尔茨海默病的认知结局:来自携带有早老素-1 E280A 突变的哥伦比亚家系的综合综述。
J Alzheimers Dis. 2024;101(2):397-415. doi: 10.3233/JAD-240360.
2
Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred.早老素 1 E280A 常染色体显性阿尔茨海默病的生物学和认知标志物:对哥伦比亚家系的综合回顾。
J Prev Alzheimers Dis. 2019;6(2):112-120. doi: 10.14283/jpad.2019.6.